Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome

  • Authors:
    • Mizuho Hiramatsu
    • Mitsutoshi Oguri
    • Kimihiko Kato
    • Hideki Horibe
    • Tetsuo Fujimaki
    • Sachiro Watanabe
    • Kei Satoh
    • Yukitoshi Aoyagi
    • Masashi Tanaka
    • Dong-Jik Shin
    • Jong Ho Lee
    • Yangsoo Jang
    • Yoshiji Yamada
  • View Affiliations

  • Published online on: April 20, 2012     https://doi.org/10.3892/ijmm.2012.976
  • Pages: 185-192
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We previously showed that the -1131T→C polymorphism (rs662799) of the apolipoprotein A-V gene (APOA5) and the C→T polymorphism (rs6929846) of the butyrophilin, subfamily 2, member A1 gene (BTN2A1) were significantly associated with an increased serum concentration of triglycerides, a decreased serum concentration of high density lipoprotein (HDL)-cholesterol, and the prevalence of metabolic syndrome (MetS) in Japanese individuals. The purpose of the present study was to examine whether these polymorphisms synergistically affect the prevalence of dyslipidemia and MetS in East Asian populations. The study populations comprised 7471 Japanese and 3529 Korean individuals in the dyslipidemia study, and 3474 Japanese and 1671 Korean individuals in the MetS study. Multivariable logistic regression analysis of combined genotypes with adjustment for age, gender and diabetes mellitus revealed that rs662799 and rs6929846 significantly and synergistically affected dyslipidemia. Japanese or Korean individuals with the C allele of APOA5 and the T allele of BTN2A1 had a 2.05- or 1.92-fold increased risk for hypertriglyceridemia and a 1.82- or 1.56-fold increased risk for hypo-HDL-cholesterolemia, respectively, compared to those with the TT genotype of APOA5 and the CC genotype of BTN2A1. Similar analysis with adjustment for age and gender revealed that Japanese individuals, but not Korean individuals, with the C allele of APOA5 and the T allele of BTN2A1 had a 2.87-fold increased risk for MetS compared to those with the TT genotype of APOA5 and the CC genotype of BTN2A1. Genetic variants of APOA5 and BTN2A1 may synergistically affect the prevalence of dyslipidemia in East Asian populations and of MetS in Japanese individuals.

Related Articles

Journal Cover

July 2012
Volume 30 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hiramatsu M, Oguri M, Kato K, Horibe H, Fujimaki T, Watanabe S, Satoh K, Aoyagi Y, Tanaka M, Shin D, Shin D, et al: Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome. Int J Mol Med 30: 185-192, 2012.
APA
Hiramatsu, M., Oguri, M., Kato, K., Horibe, H., Fujimaki, T., Watanabe, S. ... Yamada, Y. (2012). Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome. International Journal of Molecular Medicine, 30, 185-192. https://doi.org/10.3892/ijmm.2012.976
MLA
Hiramatsu, M., Oguri, M., Kato, K., Horibe, H., Fujimaki, T., Watanabe, S., Satoh, K., Aoyagi, Y., Tanaka, M., Shin, D., Lee, J., Jang, Y., Yamada, Y."Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome". International Journal of Molecular Medicine 30.1 (2012): 185-192.
Chicago
Hiramatsu, M., Oguri, M., Kato, K., Horibe, H., Fujimaki, T., Watanabe, S., Satoh, K., Aoyagi, Y., Tanaka, M., Shin, D., Lee, J., Jang, Y., Yamada, Y."Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome". International Journal of Molecular Medicine 30, no. 1 (2012): 185-192. https://doi.org/10.3892/ijmm.2012.976